Literature DB >> 29477906

Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.

Dorothée Lulé1, Sarah Böhm2, Hans-Peter Müller2, Helena Aho-Özhan2, Jürgen Keller2, Martin Gorges2, Markus Loose2, Jochen H Weishaupt2, Ingo Uttner2, Elmar Pinkhardt2, Jan Kassubek2, Kelly Del Tredici2, Heiko Braak2, Sharon Abrahams3, Albert C Ludolph2.   

Abstract

Sequential spread of TDP-43 load in the brain may be a pathological characteristic of amyotrophic lateral sclerosis (ALS). Diffusion tensor imaging (DTI) is a magnetic resonance imaging (MRI) based marker of this pathological feature. Cognitive deficits known to be present in a subset of ALS patients might act as an additional in vivo clinical marker of disease spread. N = 139 patients with ALS were tested with the Edinburgh Cognitive and Behavioural ALS screen (ECAS) in addition to DTI brain measures of pathological spread. Executive function, memory and disinhibited behaviour were selected for Cognitive-Staging criteria, as these cognitive functions are attributed to cerebral areas analogous to the pattern of MRI markers of TDP-43 pathology. ROC curve analyses were performed to define cut-off scores for cognitive stages 2 (executive function), stage 3 (disinhibited behaviour) and stage 4 (memory), and staging was performed according to the cognitive profile subsequently. Associations of Cognitive-Staging (stage 2-4) and MRI-Staging measures were determined. In total, 77 patients (55%) performed below ROC cut-off scores in either executive function or memory or both and/or were reported to have disinhibited behaviour which permitted Cognitive-Staging. The cognitive profile of patients with discrete MRI stages 2-4 correlated significantly with DTI parameters. For those patients with cognitive impairment, there was a high congruency between MRI and Cognitive-Staging with high specificity and sensitivity of executive functions for MRI stage 2, disinhibited behaviour for MRI stage 3 and moderate of memory for MRI stage 4. Cognitive impairment follows specific patterns in ALS and these patterns can be used for Cognitive-Staging with a high specificity compared to MRI-Staging. For the individual, cognitive screening is a fast and easy to apply measurement of cerebral function giving valuable information in a clinical context.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Cognition; Diffusion tensor imaging (DTI); Staging; TDP-43

Mesh:

Substances:

Year:  2018        PMID: 29477906     DOI: 10.1016/j.cortex.2018.01.004

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  18 in total

1.  Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis.

Authors:  Morten Magelssen; Trygve Holmøy; Morten Andreas Horn; Ove Arne Fondenæs; Knut Dybwik; Reidun Førde
Journal:  J Neurol       Date:  2018-09-14       Impact factor: 4.849

2.  Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence.

Authors:  Anna Behler; Hans-Peter Müller; Kelly Del Tredici; Heiko Braak; Albert C Ludolph; Dorothée Lulé; Jan Kassubek
Journal:  Ann Clin Transl Neurol       Date:  2022-06-09       Impact factor: 5.430

3.  Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).

Authors:  Sneha Chenji; Abdullah Ishaque; Dennell Mah; Esther Fujiwara; Christian Beaulieu; Peter Seres; Simon J Graham; Richard Frayne; Lorne Zinman; Angela Genge; Lawrence Korngut; Wendy Johnston; Sanjay Kalra
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

Review 4.  Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Authors:  Fabiola De Marchi; Claudia Carrarini; Antonio De Martino; Luca Diamanti; Antonio Fasano; Antonino Lupica; Mirella Russo; Simone Salemme; Edoardo Gioele Spinelli; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2021-03-27       Impact factor: 3.307

5.  MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis.

Authors:  Hans-Peter Müller; Jan Kassubek
Journal:  Front Neurosci       Date:  2018-09-26       Impact factor: 4.677

Review 6.  Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus.

Authors:  Gen Sobue; Shinsuke Ishigaki; Hirohisa Watanabe
Journal:  Front Neurosci       Date:  2018-07-12       Impact factor: 4.677

7.  A standard operating procedure for King's ALS clinical staging.

Authors:  Rubika Balendra; Ahmad Al Khleifat; Ton Fang; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-02-18       Impact factor: 4.092

8.  A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS.

Authors:  Sanjay Kalra; Hans-Peter Müller; Abdullah Ishaque; Lorne Zinman; Lawrence Korngut; Angela Genge; Christian Beaulieu; Richard Frayne; Simon J Graham; Jan Kassubek
Journal:  Neurology       Date:  2020-07-09       Impact factor: 9.910

9.  Neuronal clusterin expression is associated with cognitive protection in amyotrophic lateral sclerosis.

Authors:  J M Gregory; E Elliott; K McDade; T Bak; S Pal; S Chandran; S Abrahams; C Smith
Journal:  Neuropathol Appl Neurobiol       Date:  2019-08-28       Impact factor: 8.090

10.  Evaluating the cerebral correlates of survival in amyotrophic lateral sclerosis.

Authors:  Abdullah Ishaque; Dennell Mah; Peter Seres; Collin Luk; Dean Eurich; Wendy Johnston; Yee-Hong Yang; Sanjay Kalra
Journal:  Ann Clin Transl Neurol       Date:  2018-09-23       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.